Breast cancer is classified into distinct molecular subtypes according to the presence/absence of the estrogen receptor (ER), the progesterone-receptor (PR), the human epidermal growth factor receptor 2 (HER2), and specific gene expression profiles. This evidence concerns the gene ESR1 and breast carcinoma.